PubRank

Targeting LUNX inhibits non-small cell lung cancer growth and metastasis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 25600649)

Published in Cancer Res on January 19, 2015

Authors

Xiaohu Zheng1, Min Cheng2, Binqing Fu1, Xiaolei Fan1, Qing Wang3, Xiaoqing Yu4, Rui Sun1, Zhigang Tian5, Haiming Wei5

Author Affiliations

1: Institute of Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China. Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, China.
2: Institute of Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China. Anhui Province Hospital Affiliated Anhui Medical University, Hefei, Anhui, China.
3: Anhui Chest Hospital, Hefei, Anhui, China.
4: The First People's Hospital of Hefei, Hefei, Anhui, China.
5: Institute of Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China. Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, China. ustcwhm@ustc.edu.cn tzg@ustc.edu.cn.

Articles citing this ↘

STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget (2016) 0.81

Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. Oncotarget (2016) 0.78

SPLUNC1 Is a Significant Marker in Pleural Effusion from Lung Cancer Compared to Tuberculosis. Monoclon Antib Immunodiagn Immunother (2015) 0.75

Lung specific X protein as a novel therapeutic target for lung cancer. Oncoimmunology (2015) 0.75

Increased expression of BPI fold-containing family A member 1 is associated with metastasis and poor prognosis in human colorectal carcinoma. Oncol Lett (2017) 0.75